FDA clears KFx Medical’s new tissue fixation anchor

KFx Medical Corporation announced it has received 510K clearance from the Food and Drug Administration (FDA) for its 5mm AppianFx® Tissue Fixation Anchor.    

"This new anchor enables KFx to expand into the rapidly growing foot & ankle repair and reconstruction market, as well as other applications requiring smaller implants," remarked Tate Scott, President and CEO. "While the AppianFx® family of implants is successfully being adopted by orthopedic surgeons for a variety of repair and reconstruction procedures in the shoulder and knee, we are excited about offering Foot & Ankle surgeons anchors for small joint procedures and the early customer feedback has been nothing short of remarkable."

"Use of the KFx AppianFx anchor in foot & ankle procedures makes technically challenging cases significantly easier. There is no whip stitching which saves measurable time, and a reliable and reproducible method of tensioning with excellent fixation strength. This device is a game changer," said Aron Green, MD Seaview Orthopedics Ocean, New Jersey.

Dr. David Abdoo, DPM offered his thoughts, "This anchor is easy to use, less steps and time required for insertion, great pull out strength, and easy ability to adjust tension - Great device."

Source: KFx Medical Corporation